EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy

Chung-Shu Lee, Chung-Han Ho, Kuang-Ming Liao, Yu-Cih Wu, Chin-Chung Shu

Journal of Infection and Public Health · 2023

DOI: 10.1016/j.jiph.2023.09.005 ↗

At a glance

Journal article in Journal of Infection and Public Health, 2023. Written by Chung-Shu Lee and 4 co-authors. Institution: Department of Pulmonary and Critical Care Medicine, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan; Department of Thoracic Medicine, …. Major MEDLINE topics: Antitubercular Agents, Tuberculosis. Cited 5 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Taiwan University Hospital.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND: We investigated the impacts of the standard treatment durations of and adherence to standard anti-tuberculous therapy (ATT) on recurrence after the successful completion of tuberculosis (TB) treatment. METHODS: We recruited patients with TB who had received treatment for six or nine months from the 2008-2017 databases of the Taiwanese National Health Insurance Research Database. Treatment duration and adherence to standard ATT were analyzed for their impacts on recurrence within two years. Complete adherence to standard ATT was defined as daily use of ethambutol, isoniazid, pyrazinamide, and rifampin for the first two months, and daily use of isoniazid and rifampin for the first six months. RESULTS: A total of 33,298 TB patients with new-onset TB were identified and classified into two groups by treatment duration: six months (n = 25,849, 77.63%) and nine months (n = 7449). Sex and age distributions varied between the groups. Treatment duration did not affect TB recurrence within two years (adjusted hazard ratio (AHR): 1.18, 95% confidence interval (C.I.) [0.96-1.44], p = 0.1156). Multivariable logistic regression showed that incomplete adherence to standard anti-tuberculous therapy (80-89% and 90-99% standard anti-TB therapy, AHR: 1.57, 95% C.I. [1.26-1.95], and 1.63, 95% C.I. [1.26-2.06], respectively, p < 0.0001) increased TB recurrence. In addition, male sex, older age, and comorbidity with diabetes mellitus or chronic obstructive pulmonary disease were independent risk factors for TB recurrence within two years. CONCLUSIONS: TB recurrence was 1.54% within two years under a DOT era. TB treatment durations of six or nine months did not affect TB recurrence within two years after completion of TB treatment, but incomplete adherence to standard anti-tuberculous therapy might increase the TB recurrence rate.

Subjects

MeSH terms (MEDLINE)

Antitubercular AgentsTuberculosisHumansMaleFemaleMiddle AgedAdultRecurrenceTaiwanAgedIncidenceYoung AdultDuration of TherapyTime FactorsMedication AdherenceAdolescentIsoniazid

Author keywords

Complete adherenceTB recurrenceTreatment durationTuberculosis

Substances

Antitubercular AgentsIsoniazid

Authors and institutions

  • Department of Pulmonary and Critical Care Medicine, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University, School of Medicin…
  • Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan; Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan; Cancer Center, Taipei Municipal Wanfang…
  • Department of Internal Medicine, Chi Mei Medical Center, Chiali, Taiwan.
  • Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: ccshu@ntu.edu.tw.

Funding

  • National Taiwan University Hospital

Cite

APA

Lee, C. S., Ho, C. H., Liao, K. M., Wu, Y. C., & Shu, C. C. (2023). The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2023.09.005

Vancouver

Lee CS, Ho CH, Liao KM, Wu YC, Shu CC. The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy. Journal of Infection and Public Health. 2023. doi:10.1016/j.jiph.2023.09.005

BibTeX
@article{Lee2023,
  author = {Lee, Chung-Shu and Ho, Chung-Han and Liao, Kuang-Ming and Wu, Yu-Cih and Shu, Chin-Chung},
  title = {The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy},
  journal = {Journal of Infection and Public Health},
  year = {2023},
  doi = {10.1016/j.jiph.2023.09.005}
}
Start for free →